Continuous venovenous hemofiltration in the management of acute decompensation in inborn errors of metabolism.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 2040923.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Continuous venovenous hemofiltration was used to treat two neonates, one with maple syrup urine disease and the other with an inborn error of long-chain fatty acid oxidation. The latter infant had hypoglycemia, hyperammonemia and lactic acidosis. In both cases, acceptable biochemical control was achieved within 8 hours. This therapy offers the potential to overcome acute crises rapidly in a wide range of inborn errors of intermediary metabolism.
Medical subject headings
- Fatty Acids
- Hemofiltration
- Lipid Metabolism, Inborn Errors
- Maple Syrup Urine Disease